From October 19–22 in 2025, MacroLux participated in the 34th Annual Congress of the European Society for Gynaecological Endoscopy (ESGE 2025), held in Istanbul, Türkiye.
MacroLux Medical Technology Co., Ltd. announced the successful close of its Series B+ financing round led by B Capital. The funding will support MacroLux Medical’s continued global expansion and accelerate growth in the disposable endoscope market.
The incidence of urinary system stones has been progressively increasing, while the management approaches have been gradually transitioning towards minimally invasive procedures. Flexible Ureteroscopy Lithotripsy (FURL) achieves a transition from artificial passages to natural passages and is currently considered the safer and less invasive method for treating upper urinary tract stones.
MacroLux is a company dedicated to endoscopic diagnosis and treatment, focused on providing innovative and reliable medical solutions to healthcare professionals around the world. We are focusing on the endoscopic intervention therapy market and prioritize the development of single-use electronic endoscope products.
